November 25, 2014
The Ministry of Health, Labor and Welfare (MHLW) issued a notification on November 20 calling for the revision of the package insert for the Alzheimer’s disease treatment galantamine (brand name: Reminyl). The notification, addressed to the Federation of Pharmaceutical Manufacturers’...read more